chr9-116154437-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002581.5(PAPPA):āc.265G>Cā(p.Glu89Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,274,326 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002581.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPPA | NM_002581.5 | c.265G>C | p.Glu89Gln | missense_variant | 1/22 | ENST00000328252.4 | NP_002572.2 | |
PAPPA | XM_017014784.3 | c.265G>C | p.Glu89Gln | missense_variant | 1/21 | XP_016870273.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPPA | ENST00000328252.4 | c.265G>C | p.Glu89Gln | missense_variant | 1/22 | 1 | NM_002581.5 | ENSP00000330658.3 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150994Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000160 AC: 18AN: 1123332Hom.: 1 Cov.: 27 AF XY: 0.0000130 AC XY: 7AN XY: 539386
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150994Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73714
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.265G>C (p.E89Q) alteration is located in exon 1 (coding exon 1) of the PAPPA gene. This alteration results from a G to C substitution at nucleotide position 265, causing the glutamic acid (E) at amino acid position 89 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at